VAERS reports by lot

GSK Varicella/Shingles lot 2ZN2D: VAERS reports

27 VAERS reports list lot 2ZN2D as a GSK Varicella/Shingles vaccine, received between 2020-07-16 and 2021-06-25. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
27
Reports
0%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2126%
General / Systemic (non-local)1822%
Dermatological (non-injection-site)1518%
Neurological1113%
Musculoskeletal67%
Allergic / Anaphylactic56%
Cardiac / Cardiovascular22%
Respiratory22%
Autoimmune / Immune-mediated11%
Gastrointestinal11%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York5
Florida4
North Carolina2
Iowa2
Massachusetts2
Michigan2
Georgia2
Illinois2
West Virginia2
Rhode Island1
Idaho1
New Jersey1

Reports by month received

2020-071
2020-083
2020-093
2020-106
2020-116
2021-014
2021-023
2021-061

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.